Many ischemic stroke survivors not prescribed anticoagulants

January 10, 2017

(HealthDay)—Many patients surviving ischemic stroke are not discharged with an oral anticoagulant (OAC), according to a study published online Dec. 30 in the Journal of the American Geriatrics Society.

Emer R. McGrath, Ph.D., from Massachusetts General Hospital in Boston, and colleagues conducted a involving 1,405 individuals (mean age, 79 years) with surviving hospitalization. Reasons for nonuse of OAC were identified using structured chart review; survival was assessed one year after stroke.

The researchers found that 44 percent of participants were not prescribed an OAC at discharge even though the median CHA2DS2VASc score was 5. Fall risk, poor prognosis, bleeding history, participant or family refusal, older age, and dementia were the most frequent (non-mutually exclusive) physician reasons for not prescribing OAC. The most important independent predictors of nonuse of OACs were older age and disability. By one year, 42.5 and 19.1 percent of those not receiving an OAC and receiving an OAC at discharge had died, respectively (P < 0.001).

"To improve anticoagulation decisions and outcomes in this population, future research should focus on strategies to mitigate , improve assessment of risks and benefits of anticoagulation in individuals with atrial fibrillation, and determine whether newer anticoagulants are safer in complex elderly and frail individuals," the authors write.

Several authors disclosed financial ties to the pharmaceutical and health care industries.

Explore further: Stroke, A-fib recurrence low at one year after AF ablation

More information: Full Text (subscription or payment may be required)

Related Stories

Use of novel oral anticoagulants increasing in A-fib

June 15, 2015

(HealthDay)—For patients with atrial fibrillation hospitalized with stroke or transient ischemic attack, use of novel oral anticoagulants (NOACs) has increased over time, according to a study published online June 9 in ...

Routine oral anticoagulants may not benefit all with A-fib

January 21, 2015

(HealthDay)—Benefit from routine anticoagulation therapy to reduce risk of ischemic stroke may be unlikely in patients with atrial fibrillation (AF) and a CHA2DS2-VASc score of 1, according to a study published in the Jan. ...

Competing risks influence warfarin, thromboembolism link

November 17, 2016

(HealthDay)—For patients with nonvalvular atrial fibrillation, warfarin is associated with a reduction in thromboembolism, although the correlation is attenuated after accounting for competing death events, according to ...

Risk of ischemic, hemorrhagic stroke up with type 1 diabetes

December 13, 2016

(HealthDay)—The risks of ischemic and hemorrhagic stroke are increased with type 1 diabetes, with incrementally increasing risks with increasing hemoglobin A1c (HbA1c), according to a study published in the November issue ...

Recommended for you

Macrophages shown to be essential to a healthy heart rhythm

April 20, 2017

A Massachusetts General Hospital (MGH)-led research team has identified a surprising new role for macrophages, the white blood cells primarily known for removing pathogens, cellular debris and other unwanted materials. In ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.